Delaying a Biopsy With Serial Prostate-Specific Antigen Checkup Helps to Identify a Significant Prostate Cancer: A Strategy to Evade Unnecessary Procedures
Purpose: To differentiate a non-cancer-related temporary increase in prostate-specific antigen (PSA) triggering unnecessary biopsy, we intentionally delayed biopsy with a serial follow-up, then investigated the efficacy of this strategy in identifying a significant prostate cancer (PCa).Materials an...
Saved in:
Published in | Journal of Urologic Oncology, 20(3) pp. 177 - 185 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
대한비뇨기종양학회
31.08.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 2951-603X 2982-7043 |
DOI | 10.22465/kjuo.2022.20.3.177 |
Cover
Abstract | Purpose: To differentiate a non-cancer-related temporary increase in prostate-specific antigen (PSA) triggering unnecessary biopsy, we intentionally delayed biopsy with a serial follow-up, then investigated the efficacy of this strategy in identifying a significant prostate cancer (PCa).Materials and Methods: Retrospective data of patients who initially presented with a suspicious level of serum PSA (3–20 ng/mL), managed using the delayed strategy, and then eventually underwent biopsy were obtained from 4 tertiary centers between 2018–2020.Results: The collected 271 subjects had a median (interquartile range) PSA, age, and prostate volume of 5.03 ng/mL (4.46–7.79 ng/mL), 67 years (61–73 years), and 38 g (28–50 g), respectively. During the delay period of 8 weeks (4–19 weeks), most were managed with alpha-blockers (85.6%, n=232). Ninety-four (34.7%) experienced a PSA decrease of 20.53% (8.82–38.16). Eventual biopsy revealed 115 PCa cases (42.5%) including 82 significant ones and 46 high-risk diseases. Men with a PSA decrease had a lower probability of PCa (31.9% vs. 48%, p=0.014), a significant disease (21.3% vs. 35.0%, p=0.026), and high-risk PCa (7.4% vs. 22.0%, p=0.002) than the PSA-elevated counterparts. However, the degree of PSA decrease was not associated with the presence or the severity of PCa. In patients with PSA normalization (≤3 ng/mL), though 4 patients of them (66%) had PCa including a single significant disease, none had high-risk disease.Conclusions: About one-third of individuals initially indicated for transrectal biopsy experienced a decrease in PSA, and their chance for significant PCa was diminished. This retrospective study suggests PSA normalization could be an acceptable notion, though requires further investigation. KCI Citation Count: 0 |
---|---|
AbstractList | Purpose: To differentiate a non-cancer-related temporary increase in prostate-specific antigen (PSA) triggering unnecessary biopsy, we intentionally delayed biopsy with a serial follow-up, then investigated the efficacy of this strategy in identifying a significant prostate cancer (PCa).Materials and Methods: Retrospective data of patients who initially presented with a suspicious level of serum PSA (3–20 ng/mL), managed using the delayed strategy, and then eventually underwent biopsy were obtained from 4 tertiary centers between 2018–2020.Results: The collected 271 subjects had a median (interquartile range) PSA, age, and prostate volume of 5.03 ng/mL (4.46–7.79 ng/mL), 67 years (61–73 years), and 38 g (28–50 g), respectively. During the delay period of 8 weeks (4–19 weeks), most were managed with alpha-blockers (85.6%, n=232). Ninety-four (34.7%) experienced a PSA decrease of 20.53% (8.82–38.16). Eventual biopsy revealed 115 PCa cases (42.5%) including 82 significant ones and 46 high-risk diseases. Men with a PSA decrease had a lower probability of PCa (31.9% vs. 48%, p=0.014), a significant disease (21.3% vs. 35.0%, p=0.026), and high-risk PCa (7.4% vs. 22.0%, p=0.002) than the PSA-elevated counterparts. However, the degree of PSA decrease was not associated with the presence or the severity of PCa. In patients with PSA normalization (≤3 ng/mL), though 4 patients of them (66%) had PCa including a single significant disease, none had high-risk disease.Conclusions: About one-third of individuals initially indicated for transrectal biopsy experienced a decrease in PSA, and their chance for significant PCa was diminished. This retrospective study suggests PSA normalization could be an acceptable notion, though requires further investigation. KCI Citation Count: 0 |
Author | 김병훈 정원호 하윤수 고영휘 신택준 하지용 권세윤 정현진 Kim Tae Hyo |
Author_xml | – sequence: 1 fullname: 고영휘 organization: (영남대학교) – sequence: 2 fullname: 김병훈 organization: (계명대학교) – sequence: 3 fullname: 정원호 organization: (계명대학교) – sequence: 4 fullname: 하지용 organization: (계명대학교) – sequence: 5 fullname: 신택준 organization: (계명대학교) – sequence: 6 fullname: 권세윤 organization: (동국대학교) – sequence: 7 fullname: 정현진 organization: (대구가톨릭대학교) – sequence: 8 fullname: 하윤수 organization: (대구가톨릭대학교) – sequence: 9 fullname: Kim Tae Hyo organization: (Department of Urology, Dong-A University College of Medicine, Busan, Korea.) |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002869697$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNo9jFFLwzAUhYNMcM79Al_yLLSmadqkvtU63WCguA19K2l608WNdCSd0N_in3VV8eWcw7n3fJdoZFsLCF1HJKSUpcnt7uPYhpRQepIwDiPOz9CYZoIGnLB4NOQkClISv1-gqfemIgnnlCY8G6OvB9jL3tgGS3xv2oPv8ZvptngFzsg9fnGt72QHweoAymijcG4704DFxRbU7njAc9gfPO5avKjhdNL9CbQyjR2epe3-CbiQVoG7wzlede5UNP2wmn3KGvDGWlDgvXT9MFBQHx34K3Su5d7D9M8naPM4WxfzYPn8tCjyZaAiynjAUl1zkcWKCYC0JhnniqYMqijTCa2BgqhqEmuhmahkXVGmOElEJmSSac4gnqCbX651utwpU7bS_HjTljtX5q_rRRkREnPGRPwNXtxyaw |
ContentType | Journal Article |
DBID | ACYCR |
DOI | 10.22465/kjuo.2022.20.3.177 |
DatabaseName | Korean Citation Index |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2982-7043 |
EndPage | 185 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10037448 |
GroupedDBID | ACYCR ALMA_UNASSIGNED_HOLDINGS GROUPED_DOAJ |
ID | FETCH-LOGICAL-c1247-46fd7893c48ee6d0977c264eb19f52de2e8bd03f8f48badb24c705898a59f74e3 |
ISSN | 2951-603X |
IngestDate | Sat Feb 15 03:11:32 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1247-46fd7893c48ee6d0977c264eb19f52de2e8bd03f8f48badb24c705898a59f74e3 |
Notes | https://doi.org/10.22465/kjuo.2022.20.3.177 |
OpenAccessLink | https://www.kjuo.or.kr/upload/pdf/kjuo-20-3-177.pdf |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10037448 |
PublicationCentury | 2000 |
PublicationDate | 2022-08-31 |
PublicationDateYYYYMMDD | 2022-08-31 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-31 day: 31 |
PublicationDecade | 2020 |
PublicationTitle | Journal of Urologic Oncology, 20(3) |
PublicationYear | 2022 |
Publisher | 대한비뇨기종양학회 |
Publisher_xml | – name: 대한비뇨기종양학회 |
SSID | ssib057722579 |
Score | 2.193142 |
Snippet | Purpose: To differentiate a non-cancer-related temporary increase in prostate-specific antigen (PSA) triggering unnecessary biopsy, we intentionally delayed... |
SourceID | nrf |
SourceType | Open Website |
StartPage | 177 |
SubjectTerms | 비뇨기과학 |
Title | Delaying a Biopsy With Serial Prostate-Specific Antigen Checkup Helps to Identify a Significant Prostate Cancer: A Strategy to Evade Unnecessary Procedures |
URI | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002869697 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Urologic Oncology, 2022, 20(3), , pp.177-185 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZ2lwsXBALEW5bApyoldV42tzQtWjiAEFtpb1Xi2LulKK1Ce1j-Cn-WGdtNs1uEFi5R5Ewm08wX-xvXMybkDZe8zGBoCUb4_2DMDQ-k4TIwIwVBc1knYWmrfX5KT2fxx_Pk_Oj4S2_V0nZTDdXPP-aV_I9XoQ38ilmy_-DZTik0wDn4F47gYTjeyscT_b20aUol7im5_nEFH_nmcuBmvDAHwKYLBXaPebNQWCkAi28Oikutlts1jjlrW-HBpeuaK1D0dXHRoDC88U7DoEBstC6L3deztawVeHiNvLXRmG2AC_Bs4kG9bf3SxEPaO2tddzv43KguU4aHQHT7c75smrNxxPKQTQsmBfBdNp0wiefXRCSu1JiOUVY6kTETPZECVcjEahkzGVoRwcY9kQlehzaUzaw6kM1ZLvsTIhBL-xleD2F8qCisuFNQWDPAntheylgurIXwMKsy50w4O9KdqXCXtCc5qNr3yBzoaJCGdgNjGDx9G4YoYRz1RoGR35nGEYqR25Po5liFlfywrsfy2xaTUDlmBQ6jYXdvvzL4jRH7Wm3wpVrML1bzZTuHCOgD1qCOMoi5j8kd-PrcygU_ywBdbALBFHTSGBR2P8bV4rLmvD00BjhX05oe5zq7T-551NDcIf8BOdLNQ_Jrh3paUod6iqinDvX0APXUo5561FOLerpZ0R3qQVEP9Z0G6lD_juZ0h3m8y2Ke9jBP95h_RGbvp2fFaeC3GAkUEFvonFJTZ0DZVSy0TusQoiEFIQIQGGkSXmuuRVWHkREmFlVZVzxWGW7EKcpEmizW0WNy0qwa_YTQUZxVRmudRXUZ6wR66JSrMKprrAgFj3hKXsOLtO76i9ue3UrqObm7R_4LcrJpt_olkONN9cq6-zedPqRz |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Delaying+a+Biopsy+With+Serial+Prostate-Specific+Antigen+Checkup+Helps+to+Identify+a+Significant+Prostate+Cancer%3A+A+Strategy+to+Evade+Unnecessary+Procedures&rft.jtitle=Journal+of+Urologic+Oncology%2C+20%283%29&rft.au=%EA%B3%A0%EC%98%81%ED%9C%98&rft.au=%EA%B9%80%EB%B3%91%ED%9B%88&rft.au=%EC%A0%95%EC%9B%90%ED%98%B8&rft.au=%ED%95%98%EC%A7%80%EC%9A%A9&rft.date=2022-08-31&rft.pub=%EB%8C%80%ED%95%9C%EB%B9%84%EB%87%A8%EA%B8%B0%EC%A2%85%EC%96%91%ED%95%99%ED%9A%8C&rft.issn=2951-603X&rft.eissn=2982-7043&rft.spage=177&rft.epage=185&rft_id=info:doi/10.22465%2Fkjuo.2022.20.3.177&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10037448 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2951-603X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2951-603X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2951-603X&client=summon |